%0 Generic
%A Mok, T.
%A Nakagawa, K.
%A Rosell, R.
%A Lee, K.
%A Corral, J.
%A Migliorino, M. R.
%A Pluzanski, A.
%A Linke, R.
%A Devgan, G.
%A Sbar, E.
%A Quinn, S.
%A Wang, T.
%A Wu, Y.
%T Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-Positive NSCLC
%D 2018
%@ 1556-0864
%U https://hdl.handle.net/10668/27249
%K dose reduction
%K non-small cell lung cancer
%K Dacomitinib
%~